tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
PremiumThe FlyDiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
1M ago
DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
Premium
The Fly
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
2M ago
DiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement
PremiumThe FlyDiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement
2M ago
DiaMedica Announces $30.1M Private Placement for DM199
Premium
Company Announcements
DiaMedica Announces $30.1M Private Placement for DM199
2M ago
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
Premium
The Fly
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
2M ago
ReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment
PremiumCompany AnnouncementsReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment
3M ago
DiaMedica Therapeutics to be included in Russell 2000, 3000 Indexes
Premium
The Fly
DiaMedica Therapeutics to be included in Russell 2000, 3000 Indexes
3M ago
Promising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
Premium
Ratings
Promising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100